3 patents
Utility
Use of Substituted Hexitols Including Dianhydrogalactitol and Analogs to Treat Neoplastic Disease and Cancer Stem Cells Including Glioblastoma Multiforme and Medulloblastoma
23 Jun 22
The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of glioblastoma multiforme and medulloblastoma.
Dennis M. Brown, Jeffrey Bacha, Sandra Dunn
Filed: 8 Mar 22
Utility
Use of Substituted Hexitols Including Dianhydrogalactitol and Analogs to Treat Neoplastic Disease and Cancer Stem Cells Including Glioblastoma Multiforme and Medulloblastoma
12 May 22
The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of glioblastoma multiforme and medulloblastoma.
Dennis M. Brown, Jeffrey Bacha, Sandra Dunn
Filed: 24 Jan 22
Utility
Methods for Treating a Cancer Resistant to at Least One Tyrosine Kinase Inhibitor
19 Aug 21
Methods and compositions suitable for the treatment of malignancies in subjects with a germline deletion polymorphism that blocks the activity of thymidine kinase inhibitors in triggering apoptosis in tumor cells or in subjects having a mutation in or a dysregulation of the AHI-1 gene are disclosed.
Dennis M. Brown, Jeffrey A. Bacha, William J. Garner
Filed: 17 Feb 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first